Loading data for LFSC — first visit, this takes a few seconds.
F/m Emerald Life Sciences... (LFSC)
NasdaqGM: LFSC
· 实时价格 · USD
47.58
-0.45 (-0.94%)
收盘价： Aug 26, 2026, 8:00 PM
F/m Emerald Life Sciences Innovation ETF（LFSC）ETF 价格、持仓与分析
-0.94% (1D)
暂无数据
| 买价 | 47.25 |
| 市值 | n/a |
| 管理资产规模（AUM） | 124.88M |
| 净值（NAV） | 47.45 |
| 贝塔（Beta） | 无 |
| 每股收益（EPS，过去十二个月） | 无 |
| 市盈率（PE，过去十二个月） | 无 |
| 流通股数 | 无 |
| 成立日期 | Oct 30, 2024 |
| 卖价 | 47.58 |
| 成交量 | 1,403 |
| 平均成交量（20日） | 4,884 |
| 开盘价 | 47.59 |
| 前收盘价 | 48.03 |
| 日内区间 | 47.41 - 47.59 |
| 52周区间 | 27.67 - 48.78 |
| 持仓 | 无 |
| 费用率 | 0.54% |
关于LFSC
The fund is an actively managed exchange-traded fund (“ETF”) and invests primarily in equity securities of life science companies selected by Emerald Mutual Fund Advisers Trust, the fund’s investment sub-adviser, under the supervision of the adviser. Under normal market conditions, the fund invests at least 80% of its net assets in equity securities issued by life science companies demonstrating innovation.
前十大持仓 占资产的57.58%
| 名称 | 代码 | 权重 |
|---|---|---|
| Travere Therapeutics... | TVTX | 7.84% |
| Spyre Therapeutics I... | SYRE | 7.40% |
| Cogent Biosciences I... | COGT | 7.23% |
| Corcept Therapeutics... | CORT | 6.82% |
| Livanova PLC | LIVN | 6.67% |
| Guardant Health Inc | GH | 5.95% |
| Billiontoone Inc Ord... | BLLN | 4.91% |
| Cytokinetics Inc | CYTK | 3.82% |
| Mirum Pharmaceutical... | MIRM | 3.58% |
| Axsome Therapeutics ... | AXSM | 3.36% |
